Abstract. Missed abortion (MA) refers to a pregnancy in which there is fetal demise without outside intervention, and additionally no uterine activity that may expel the product of conception (POC) prior to 20 weeks of gestation. Chromosomal abnormalities are the primary cause of MA and single gene defects in the POC may additionally be associated with MA; however, few studies have been conducted on the identification of mutations by whole-exome sequencing. In the present study, 19 unrelated MA POCs were collected and whole-exome sequencing was performed on the POC. Bioinformatics analysis was performed on sequence variants from a list of 286 selected candidate genes that were associated with early embryonic lethality and MA. A total of 36 sequence variants in 32 genes potentially associated with MA were identified in 15 out of 19 patients. Gene Ontology analysis suggested that these genes were enriched in biological processes in early embryonic development, including 'chordate embryonic development', 'cell proliferation' and 'forebrain development'. Further strict in silico bioinformatics analysis predicted that the LIM domain-binding protein 1 (c.662C>T; p.S221L) variant was a highly pathogenic variant. In conclusion, the results of the present study provide researchers and clinicians with a better understanding of the etiology and molecular mechanism of human embryonic lethality and MA.
Introduction
The term 'missed abortion (MA)', a type of miscarriage, refers to a pregnancy in which there is fetal demise without outside intervention, and also no uterine activity that may expel the product of conception (POC) prior to 20 weeks of gestation (1) . Multiple epidemiological factors, including parental or embryonic chromosomal abnormalities, infection, immunological factors, hereditary thrombophilia, uterine abnormalities, endocrinological disorders, and nutritional and environmental factors have been associated with miscarriage (2, 3) . Cytogenetic analysis of the retained POC is thought to be the most effective test for identifying the cause of MA (4) . Chromosomal abnormalities are the primary cause of MA, with errors in chromosome number, copy number variations and abnormalities resulting in structural defects accounting for 60-80% of MAs (4) (5) (6) (7) (8) . However, the cause of 20-40% of MAs remains unknown, despite current detection methods.
High-throughput sequencing technology is currently widely used for identifying genetic alterations associated with MAs of unknown causes. Single gene defects in the POC may additionally be associated with MA; however, few studies have used high-throughput sequencing methods to study genetic defects in the POC.
In the present study, 19 unrelated MA POCs were collected and whole-exome sequencing (WES) was performed on the POC. Bioinformatics analysis was performed on sequence variants from a list of 286 selected candidate genes that are associated with early embryonic lethality and MA. A total of 36 sequence variants in 32 genes potentially associated with MA were identified in 15 out of 19 POCs. Gene Ontology (GO) analysis suggested that these genes were enriched in biological processes in early embryonic development, including 'chordate embryonic development', 'cell proliferation' and 'forebrain development'. The novel genes and genetic alterations may increase knowledge of MA pathogenesis and aid future genetic counseling for MA. (9) , Loss Intolerance (pLI) (10) and Haploinsufficiency Score (11) were used for evaluating the haploinsufficiency effect of each gene. DECIPHER database (https://decipher.sanger.ac.uk/) was used for identifying the previous published copy number variations and single nucleotide variants and the associated disease phenotypes. DAVID Bioinformatics Resources 6.7 (https://david-d.ncifcrf.gov/) was used for conducting the GO analysis.
Materials and methods

Subjects
Sanger sequencing validation. Sanger sequencing was used to validate the WES results and verify whether the potentially disease-causing variants identified were true variants or sequencing artifacts. Sanger sequencing for the LDB1 variant in the POC QW013 was performed using gene-specific primers as follows; the forward primer was 5'-AGG AGT GTC ACA ATG CTC AGA TGA T-3' and the reverse primer was 5'-GTA AAC GGA GAC TCA GAT GGG AGA G-3'. Cycling parameters were an initial denaturation at 94˚C for 5 min followed by 35 cycles of denaturation at 94˚C for 20 sec, annealing at 60˚C for 30 sec and extension at 72˚C for 1 min, followed by a final extension at 72˚C for 5 min. TransStart FastPfu DNA polymerase (TransGen Biotech Co., Ltd., Beijing, China) was used in the PCR reaction.
Results
WES analysis of MA embryos.
A total of 19 patients (between 23 and 42 years of age) with MA participated in the present study (Table I) . A total of 19 MA POCs (chorionic villus from 5-12 gestational weeks) were examined. The karyotypes of all POC were normal (Table I) . WES was performed for each POC. The sequencing depth of each WES is listed in Table I . Therefore, WES-detected sequence variants identified in each embryo were focused upon. The present study aimed to identify direct sequence variants causing MA, which should not exist in live human beings. Therefore, polymorphisms with a minor allele frequency absent in the dbSNP, 1000 Genomes, ESP6500, ExAC and gnomAD databases were retained. Subsequently, all variants were further filtered, according to the list of 286 selected candidate genes that were associated with early embryonic lethality and MA. A total of 36 sequence variants in 32 genes potentially associated with MA were identified in 15 out of 19 patients (data not shown). All variants were in the heterozygous state.
In silico analysis of the variants. GO analysis suggested that these 32 genes were enriched in biological processes in early embryonic development, including 'chordate embryonic development', 'cell proliferation' and 'forebrain development' (Fig. 1) . In silico analysis predicted that 12 of 36 variants were considered to be pathogenic alleles by four online prediction tools, including Polyphen-2, SIFT, Mutation Taster and FATHMM-MKL (Table II) . As all the variants were heterozygous, the present study aimed to determine whether the heterozygous state of the variants influenced disease tolerance. The variation intolerance scores were analyzed using three scoring systems, including the Constraint Metrics Z score for missense variation (9), Loss Intolerance (pLI) (10) and Haploinsufficiency Score (11) . Out of the 12 genes, LIM domain binding 1 gene (LDB1) was the only gene that was predicted as intolerant to variation by the three scoring systems (Table II) . Sequence variant c.3064C>T; p.P1022S (Table II) in another gene, death induced obliterator-1 (DIDO1), was additionally a potential candidate gene causing MA. This variant was predicted to be a pathogenic allele by Polyphen-2, MutationTaster and FATHMM-MKL. The variant in DIDO1 was considered loss-of-function-intolerant, as predicted by the Constraint Metrics Z score for missense variation and pLI (Table II) . Therefore, it was hypothesized that the variant in LDB1 (c.662C>T; p.S221L) and DIDO1 (c.3064C>T; p.P1022S) was likely to be associated with embryo lethality and MA.
Analysis of the variant in LDB1. LDB1 serves important roles in the regulation of a variety of processes in early embryonic development, including heart formation (12), head and brain development (12) (13) (14) (15) (16) (17) , limb patterning (18) , and eye development (16) . In previous studies, the development of LDB1 null mutant mice was arrested at embryonic day 8.5 (E8.5) and mice succumbed at E9-E10 (12,19) . Therefore, LDB1 may be a good candidate gene for human early embryonic lethality and MA. In the present study, the heterozygous c.662C>T variant in LDB1 was also validated by Sanger sequencing (Fig. 2A) . DNA samples from the patient and her husband were unavailable, therefore it was not possible to analyze whether this variant was inherited or generated de novo. This variant and the flanking region were additionally highly conserved in humans and other animals including zebrafish (Fig. 2B) , which reflects the highly conserved role of LDB1 in early embryonic development across different species.
Discussion
In the present study, WES was performed on 19 POC and using a strict filtering strategy, 36 rare sequence variants associated with MA were identified. GO analysis suggested that these 32 genes were enriched in biological processes in early embryonic development, including 'chordate embryonic development', 'cell proliferation' and 'forebrain development'. Further strict in silico bioinformatics analysis predicted the LDB1 (c.662C>T; p.S221L) variant to be a highly pathogenic variant.
Previous studies suggest that chromosomal abnormalities account for 60-80% of MA cases (4) (5) (6) (7) (8) . However, to the best of the authors' knowledge, no studies have been performed on POC using NGS technology to elucidate single gene defects. Therefore, the present study attempted to dissect the genetic causes of the remaining 20-40% of MA cases. A total of 36 rare sequence variants in 32 genes potentially associated with MA were identified in 15 out of 19 patients. Of the 32 genes, seven genes [lycine acetyltransferase 2A, lycine demethylase 1A (KDM1A), spalt like transcription factor 4, heat shock transcription factor 1, integrator subunit complex 1, patched 1 and LDB1 is a critical gene involved in embryonic morphogenesis (12) (13) (14) (15) (16) (17) 19) . LDB1 gene deficiency leads to early embryonic arrest and embryo loss between E9-E10 (12, 19) . Therefore, LDB1 is a good candidate gene for embryonic lethality. Additionally, LDB1 was searched for in Online Mendelian Inheritance in Man (OMIM) and PubMed; however, no study demonstrating LDB1 gene mutations associated with developmental diseases was identified. Therefore, it was hypothesized that human embryos harboring pathogenic mutations in LDB1 may lead to embryonic lethality, meaning that no child carrying the LDB1 pathogenic mutation would be born; this may explain why no LDB1 mutation was observed in OMIM. Furthermore, in the present study, the c.662C>T; p.S221L variant in LDB1 was predicted as a pathogenic allele by a number of prediction tools, which, along with the extreme rarity and conservation of the variant and flanking regions, suggested that the LDB1 mutation in the POC was associated with MA.
Ablation of DIDO1 in mice causes embryonic lethality during the gastrulation stage (20) . DIDO heterozygous deletion mice demonstrate abnormalities in their spleen, bone marrow and peripheral blood (21) . By checking the DECIPHER database (https://decipher.sanger.ac.uk/), two heterozygous missense variants in DIDO1 were identified, one of which may be associated with abnormalities in the head, cardiovascular system, ear, integument, nervous system and skeletal system. Therefore, the variant in the present study may also be associated with embryonic developmental abnormalities. , not available. Mutation Taster: The probability value is the probability of the prediction, i.e., a value close to 1 indicates a high 'security' of the prediction. D, probably deleterious; N, polymorphism; A, known to be deleterious. FATHMM-MKL values >0.5 are predicted to be deleterious, while those <0.5 are predicted to be neutral or benign. D, deleterious; N, neutral; M Z score, missense Z score: Positive Z scores indicate increased constraint (intolerance to variation) and therefore that the gene had fewer variants than expected. Negative Z scores are given to genes that exhibit more variants than expected. pLI: The closer pLI is to one, the more LoF-intolerant the gene appears to be. pLI >= 0.9 was considered as an extremely LoF intolerant set of genes. HI, high ranks (e.g. 0-10%) indicate a gene is more likely to exhibit HI; low ranks (e.g., 90-100%) indicate a gene is more likely to not exhibit HI. m, missense; s, stopgain; Aa, amino acid; LoF, loss of function; HI, haploinsifficiency; pLI, loss intolerance. In conclusion, the present study identified 36 rare sequence variants in 19 POCs associated with MA. Further bioinformatics analysis predicted that the LDB1 (c.662C>T; p.S221 L) variant is a highly pathogenic variant and may be associated with embryonic lethality. Taken together, the results of the present study provide researchers and clinicians with a better understanding of the etiology and molecular mechanism of human embryonic lethality and MA.
